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Organotypic specificity of key RET  
adaptor-docking sites in the pathogenesis  
of neurocristopathies and renal  
malformations in mice
Sanjay Jain,1,2,3 Amanda Knoten,1 Masato Hoshi,1 Hongtao Wang,4 Bhupinder Vohra,5  
Robert O. Heuckeroth,3,4,6 and Jeffrey Milbrandt1,2,3,5
1Department of Internal Medicine (Renal Division), 2Department of Pathology, 3HOPE Center for Neurological Disorders, 4Department of Pediatrics, 
5Department of Genetics, and 6Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri.
The	receptor	tyrosine	kinase	ret	protooncogene	(RET)	is	implicated	in	the	pathogenesis	of	several	diseases	and	
in	several	developmental	defects,	particularly	those	in	neural	crest–derived	structures	and	the	genitourinary	
system.	In	order	to	further	elucidate	RET-mediated	mechanisms	that	contribute	to	these	diseases	and	decipher	
the	basis	for	specificity	in	the	pleiotropic	effects	of	RET,	we	characterized	development	of	the	enteric	and	auto-
nomic	nervous	systems	in	mice	expressing	RET9	or	RET51	isoforms	harboring	mutations	in	tyrosine	residues	
that	act	as	docking	sites	for	the	adaptors	Plcγ,	Src,	Shc,	and	Grb2.	Using	this	approach,	we	found	that	devel-
opment	of	the	genitourinary	system	and	the	enteric	and	autonomic	nervous	systems	is	dependent	on	distinct	
RET-stimulated	signaling	pathways.	Thus,	mutation	of	RET51	at	Y1062,	a	docking	site	for	multiple	adaptor	
proteins	including	Shc,	caused	distal	colon	aganglionosis	reminiscent	of	Hirschsprung	disease	(HSCR).	On	
the	other	hand,	this	mutation	in	RET9,	which	encodes	an	isoform	that	lacks	the	Grb2	docking	site	present	in	
RET51,	produced	severe	abnormalities	in	multiple	organs.	Mutations	that	abrogate	RET-Plcγ	binding,	previ-
ously	shown	to	produce	features	reminiscent	of	congenital	anomalies	of	kidneys	or	urinary	tract	(CAKUT)	
syndrome,	produced	only	minor	abnormalities	in	the	nervous	system.	Abrogating	RET51-Src	binding	pro-
duced	no	major	defects	in	these	systems.	These	studies	provide	insight	into	the	basis	of	organotypic	specificity	
and	redundancy	in	RET	signaling	within	these	unique	systems	and	in	diseases	such	as	HSCR	and	CAKUT.
Introduction
Aberrant signaling by receptor tyrosine kinases (RTKs) leads to 
congenital malformations, cancer, and stem cell renewal defects. 
Upon activation, RTKs typically interact with intracellular adaptor 
proteins (PLCγ, SRC, SHC, GRB2) via docking phosphotyrosines 
to activate intracellular signaling cascades, such as PKC, AKT, and 
MAPK, that regulate cellular proliferation, survival, migration, 
and self renewal (1). While studies of mutant mice have elucidated 
physiological roles of several RTKs, little is known about the rela-
tive contributions of individual signaling cascades in producing 
the diverse phenotypes that result from RTK dysfunction.
Mutations in rearranged during transfection (RET) protoon-
cogene, a transmembrane RTK, cause multiple human diseases, 
particularly those affecting neural crest–derived structures (enteric 
ganglia, parasympathetic and sympathetic ganglia, thyroid C cells, 
and adrenal medulla) (2). Inactivating RET mutations are a com-
mon cause of Hirschsprung disease (HSCR) (3), or distal intesti-
nal aganglionosis, as well as renal agenesis (4). In contrast, activat-
ing RET mutations lead to human multiple endocrine neoplasia 
(MEN) syndromes 2A and 2B, 2 life-threatening familial cancer 
predisposition syndromes. Recently, RET mutations have been 
found in patients presenting with multiple abnormalities, includ-
ing HSCR, with congenital anomalies of kidneys or urinary tract 
(CAKUT), or HSCR and MEN2, or CAKUT and MEN2 (5–7). It is 
unclear how RET-mediated signaling cascades lead to anomalies in 
isolated or combined presentation of these anomalies.
RET signaling is activated by the formation of a receptor com-
plex that includes a member of the glial cell line–derived neuro-
trophic factor (GDNF) family ligands (GFLs), which includes 
GDNF, Neurturin, Artemin, and Persephin, along with a GDNF 
receptor α (GFRα) coreceptor (GFRα1–4) (8). The specificity of 
these interactions is dependent on the coreceptor-ligand interac-
tion, with the RET tyrosine kinase serving as a common signal-
ing component. A number of studies in mice have defined the 
importance of Ret signaling in the development and maintenance 
of the peripheral nervous system (PNS), with particular empha-
sis on the autonomic nervous system (ANS), enteric nervous sys-
tem (ENS), and the urinary and reproductive systems (9–13). For 
example, mice lacking Gdnf, its cognate coreceptor Gfrα1, or Ret 
all have similar and severe deficits that include complete intestinal 
aganglionosis, agenesis of sphenopalatine ganglia, migration and 
neuronal projection defects in the sympathetic ganglia, and bilat-
eral renal agenesis (10, 14–20).
RET activation results in phosphorylation of key docking tyro-
sines that bind to several intracellular adaptor proteins such as 
SRC (at Y981), PLCγ (at Y1015), SHC, FRS2, IRS1 and -2, ENIGMA, 
DOKs 4, 5 and 6 (at Y1062), and GRB2 (at Y1096) (21). Recruitment 
of SRC to RET Y981 activates the MAPK pathway, while recruit-
ment of PLCγ binding to RET Y1015 primarily activates the PKC 
pathway (21). The RET Y1062 phosphotyrosine serves as a dock-
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ing site for multiple adaptors. It primarily supports SHC binding 
to recruit either the GRB2-SOS complex leading to MAPK activa-
tion or GRB2-GAB1 to stimulate PI3K/AKT signaling. GRB2 also 
binds directly to phospho-Y1096, where it preferentially activates 
PI3K/AKT signaling (22).
There are 2 major alternative splice isoforms of RET, RET9 and 
RET51, that may differentially modulate RET-activated intra-
cellular signaling cascades. RET9 (1072 aa) and RET51 (1114 aa) 
diverge after residue 1063 and thus are identical except for the 
C-terminal cytoplasmic domain (23). RET51 carboxyl terminus 
contains an additional docking tyrosine, Y1096, 
for GRB2. The physiologic roles of these 2 isoforms 
and the signaling pathways emanating from specific 
phosphorylated tyrosine docking sites have been 
studied in vitro, but information in vivo is limited. 
The relative importance of the RET isoforms and 
particular docking sites has differed depending on 
the system investigated (24–27). For example, in mice 
exclusively expressing chimeric mouse-human WT 
Ret9 or Ret51, only Ret9 supported normal kidney 
or ENS development (28). However, normal kidney 
development is supported in mice expressing either 
WT human RET9 or RET51. Only when individual 
RET docking sites were mutated did the distinct 
roles of these key signaling pathways and isoforms in 
genitourinary development become apparent (29).
To delineate the RET signaling pathways criti-
cal for the formation of the PNS, we characterized 
the ENS and ANS in 10 different mutant mice in 
which key RET docking sites were mutated in both 
the RET9 and RET51 isoforms. We found that either 
RET9 or RET51 could support normal ENS develop-
ment, contrary to a previous report (28); however, 
dramatic differences were observed when individual 
phosphotyrosine docking sites were mutated in the 
context of the RET9 vs. RET51 isoform. In general, 
mice deficient in a particular adaptor site in the 
RET51 context exhibited abnormalities that were 
less severe than those observed in mice harboring 
the same mutation in the context of RET9, indicat-
ing that the additional Grb2 site (Y1096) in RET51 
provides redundancy in both the ENS and PNS. For example, ENS 
and parasympathetic ganglia showed minimal deficits in mice 
expressing RET51 docking site mutants, whereas mice expressing 
comparable RET9 mutations showed varying degrees of intestinal 
aganglionosis and agenesis of key parasympathetic ganglia as well 
as sympathetic nervous system defects. The phenotypes of these 
RET mutants (singly or in combination) resemble HSCR and/or 
CAKUT, including the characteristic incomplete penetrance and 
variable expressivity of these syndromes. By systematically exam-
ining the role of each adaptor singly or in combination with the 
absence of the Y1096 Grb2-binding site, these studies provide 
valuable insights into the mechanistic basis for the variable phe-
notypes observed in HSCR or CAKUT.
Results
Parasympathetic, but not enteric or sympathetic, ganglia require RET51 
isoform for proper development. To investigate the relative contri-
butions of the 2 major RET isoforms, RET9 and RET51, in PNS 
development, we studied mice that exclusively express 2 copies 
of WT human RET9 or RET51. These knockin mice, and each of 
the homozygous RET mutants studied, were generated previously 
using homologous recombination of human RET cDNAs into the 
endogenous Ret locus (knockout-knockin approach) (Figure 1  
and Table 1) (29). All analyses performed in this study were on 
homozygous mice. For PNS analyses, we selected structures that 
are severely affected in Ret- or GFL-null mice, including the ENS 
and the cranial parasympathetic sphenopalatine ganglia (SPG) 
and superior cervical sympathetic ganglia (SCG) of the ANS (9, 
10, 19). Most of the analyses were performed on newborn mice 
Table 1
List of RET-mutant mice used
Homozygous mutant studied Simple name used
RetRET9/RET9	 RET9
RetRET51/RET51	 RET51
RetRET51(Y981F)/RET51(Y981F)	 RET51(Y981F)
RetRET51(Y1015F)/RET51(Y1015F)	 RET51(Y1015F)
RetRET51(Y1062F)/RET51(Y1062F)	 RET51(Y1062F)
RetRET51(Cdel)/RET51(Cdel)	 RET51(Cdel)
RetRET9(Y981F)/RET9(Y981F)	 RET9(Y981F)
RetRET9(Y1015F)/RET9(Y1015F)	 RET9(Y1015F)
RetRET9(Y1062F)/RET9(Y1062F)	 RET9(Y1062F)
RetRET9(51C)/RET9(51C)	 RET9(51C)
Shown are the homozygous mutant mice expressing the knocked in 
human RET alleles and the simplified allele names that are used in the 
manuscript.
Figure 1
Schematic of the various RET-mutant mice used in this study. (A) Simplified diagram 
of mutant or WT human RET cDNAs homologously recombined into exon 1 (black box) 
of the mouse Ret locus using knockout-knockin approach (29). (B) Schematic of the 
different WT RET9, RET51, and their respective mutant knocked in alleles is shown. 
The different domains and sizes of RET9 and RET51 are indicated. The area of diver-
gence between the 2 RET isoforms is indicated in red or blue. Also indicated are the 
key docking tyrosine (Y) residues, the major intracellular adapters that dock at these 
tyrosines, and the downstream signaling cascades. Homozygous mice were gener-
ated that harbor Tyr-to-Phe (Y to F) mutations for each of the indicated Tyr except 
Y1096. In the RET51(Cdel) allele, residues 1063–1072 of RET9 were replaced with 
residues 1063–1072 of RET51. This results in a receptor that is essentially RET51 
with a deletion of residues 1073–1114, including Y1096. In the RET9(51C) allele, 
residues 1063–1072 of RET51 were replaced with residues 1063–1072 of RET9. 
This results in a receptor that is essentially similar to RET9 with C terminus of RET51, 
including Y1096. Note Grb2 can directly bind to RET51 and also indirectly to Y1062 
in both RET9 and RET51.
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(P0), as these structures are largely 
developed at birth, and many of these 
mutant animals die shortly after birth 
due to severe renal (29) or intestinal 
abnormalities (see below).
To determine whether the intestinal 
aganglionosis in Ret-null mice could 
be attributed to a specific Ret isoform, 
we used acetylcholinesterase (AChE) 
staining to visualize the ENS in mice 
expressing solely RET51 (RetRET51/RET51) 
or RET9 (RetRET9/RET9). In a previous 
report, Ret9 was found to be critical 
for intestinal innervation (28); how-
ever, we found that either isoform 
was capable of supporting ENS devel-
opment. AChE-stained neurons and 
a normal myenteric neuronal plexus 
were detected throughout the small 
and large bowel in these mutant mice 
(Figure 2A; data not shown).
Previous analysis of Ret-null and 
Artemin-null mice showed that Ret 
signaling is important for sympathet-
ic neuron precursor migration and 
axonal projection (10, 30). In these 
mutants, the SCG fails to migrate to 
its proper location, resulting in accom-
panying abnormalities in projections 
to the submandibular gland and mus-
cles of the eye. The stellate and sym-
pathetic chain ganglia and their axo-
nal projections are also abnormally 
developed in these mutant mice. We 
next searched for isoform-specific 
differences in sympathetic nervous 
system development. We used tyro-
sine hydroxylase (TH) whole-mount 
immunohistochemistry to visualize 
the sympathetic nervous system in 
homozygous RET9 and RET51 mice. 
We found that it developed normally, 
with properly located SCGs and nor-
mal innervation of its targets and 
normally formed sympathetic chain 
(Figure 2B and data not shown).
Finally, we investigated to deter-
mine whether RET9 and RET51 mice 
were able to support parasympathetic 
ganglia development. The SPG, which 
innervates the harderian/lachrymal 
glands, fails to develop in Ret-null mice 
due to defective precursor proliferation 
(9). Histological analysis of P0 head 
sections using Nissl staining revealed 
normally localized SPGs in RET51 
mice (Figure 2C). However, a subset 
of RET9 mice had unilateral agenesis 
of the SPG (25%), which was accom-
panied by reduced harderian gland 
Figure 2
RET51 is sufficient to support ENS and sympathetic nervous system development and is neces-
sary for the development of cranial parasympathetic ganglia. (A) RET9 and RET51 can both sup-
port normal ENS development. Whole-mount AChE staining (to visualize ENS formation) from WT 
or the indicated RET51 and RET9 mice (at postnatal day zero, P0) show typical dense reticular, 
honeycomb-like distal colon staining, indicating normal ENS colonization by both RET isoforms. 
(B) Redundant roles of RET isoforms in development of sympathetic ganglia. Whole-mount TH 
immunohistochemistry (brown color) shows normally located SCG and normal projections to the 
eye (white arrowhead) and submandibular gland (SM, black arrowheads). (C) RET9 alone is 
unable to fully support parasympathetic ganglia development. Nissl-stained sections of head from 
P0 mice show normal location of SPG in WT and RET51 (arrows) mice, but a subset of RET9 mice 
show unilateral SPG agenesis (dashed oval) (see E–H for orientation). (D) Reduced harderian 
gland innervation in RET9 mice (1- to 2-month-old mice) was observed with anti-TuJ1 immuno-
histochemistry (red fibers). While TuJ1-positive fibers surround almost all acini in WT and RET51 
mice, RET9 harderian glands show reduced innervation consistent with incompletely penetrant 
unilateral agenesis. (E–H) Anatomical and histological landmarks for SPG analysis. Vertical bar 
in E shows approximate level of histological sections. (F) Coronal section showing SPG location 
(white arrow); boxed area is shown at higher magnification in G, which also represents images 
in C and Figure 7A. (H) Closer view of SPG of one side denotes approximate representation of 
images in Figure 7B. Scale bars: 400 μm (A); 600 μm (B); 200 μm (C); 100 μm (D); 50 μm (inset); 
F, 1 mm. br, brain; sep, septum; mu, eye muscles; np, nasopharynx; mn, maxillary nerves; oa, 
orbital artery; ov, orbital vein; spa, sphenopalatine ganglion.
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innervation compared with WT mice as assessed by TuJ1 immuno-
histochemistry (WT = 10821 ± 977, n = 3; RET9 = 2040 ± 297, 
n = 3; mean innervation area pixel2 ± SEM, P < 0.001); innervation in 
RET51 and WT harderian glands were similar (RET51 = 8862 ± 661, 
n = 3, mean ± SEM, P = 0.1) (Figure 2D). These results indicate that 
the WT forms of RET9 and RET51 have redundant roles in mor-
phologically normal ENS and sympathetic nervous system develop-
ment. However, RET9 alone is insufficient to promote proper SPG 
development, suggesting that Grb2-mediated signaling through 
Y1096 is important in this process.
Signaling through RET51-Y1062 is essential for distal colon innervation. 
Four phosphotyrosines in the RET cytoplasmic domain serve as 
major docking sites for intracellular adaptors that initiate down-
stream signaling cascades. We next sought to delineate which of 
these RET docking sites, Y981 (site for Src interaction), Y1015 
(site for Plcγ interaction), Y1062 (interacts with Shc and other 
intracellular adaptors) and Y1096 (a site only present in RET51 
that interacts with Grb2), play critical roles in the ENS in order to 
gain new mechanistic insights into RET-mediated HSCR.
We used AChE staining to examine the ENS of mice expressing 
human RET51 in which each of these docking sites was individu-
ally mutated (Y to F mutants) or, in the case of Y1096, by using a 
C-terminal deletion mutant (RET51Cdel) (Figure 1 and Table 1) 
that lacks this residue (25, 26, 28, 29). We observed remarkable 
differences in colonic ENS structure in these mutants, which were 
highly reminiscent of long (aganglionic segment proximal to the 
rectosigmoid colon) and short segment (aganglionosis confined 
to rectosigmoid region) HSCR. The enteric plexus and neurons in 
the distal bowel were absent (i.e., aganglionosis) in mice expressing 
the RET51(Y1062F) mutant (lacks Shc adaptor site), with the length 
of aganglionic segment varying from the distal colon only to total 
colon aganglionosis (Figure 3). Notably, these mice do not have sig-
nificant renal abnormalities (29), but do not survive to adulthood 
due to complications of the HSCR-like phenotype (i.e., megacolon, 
ruptured bowel). Thus, abrogating RET-Shc–mediated signaling has 
a severe effect on the ENS, but not on urogenital development.
Further, we found that RET51(Y1015F) mice (lack RET-stimulated 
Plcγ signaling) do not have major abnormalities in the ENS in con-
trast, with the crucial importance of this pathway in supporting 
normal urogenital development (29). The majority of these mutant 
mice showed normal distal colon innervation (13/16), with only a 
small subset manifesting distal colon hypoganglionosis (Figure 3 
and Figure 4B). We also found normal intestinal innervation in 
RET51(Cdel) mice (RET51 C-term deletion, which lack the direct 
Grb2 binding site Y1096), RET9(51C), or RET51(Y981F) (lack Src 
binding site) (Figure 3, Figure 4B, and data not shown). The pheno-
Figure 3
Essential role of the RET-Shc multidocking site in distal colon innervation. To determine roles of individual RET adaptor sites in ENS devel-
opment, AChE whole-mount staining to visualize the ENS was performed on intestines (P0) of the indicated adaptor mutants in the context 
of RET51 isoform (Y981F, Src adaptor; Y1015F, Plcγ adaptor; Y1062F, Shc adaptor; or null, KO). Neuronal plexus and ganglion formation, 
depicted by typical reticular, honeycomb like staining pattern at ileocecal (IC) junction and distal colon, occurs in all adaptor mutants except for 
RET51(Y1062F). The RET51(Y1062F) image shows distal colon with absent enteric ganglia and plexus, but readily visible thick extrinsic nerve 
fiber bundles similar to those observed in Ret-null mice. Varying degrees of colon aganglionosis were seen in RET51(Y1062F) mice. Compared 
with aganglionosis in terminal ileum (TI) of Ret-KO mice, AChE staining of the intestines in RET51(Y1062F) mice detected both a neuronal plexus 
and ganglia in the TI. The schematic summarizes the extent of bowel colonization by ENS precursors in mutant mice. For RET51(Y1062F), each 
pentagon represents the location of the most distal enteric ganglion cell in an individual mutant; for other mouse lines, single pentagons represent 
the entire group, since none of these mice had bowel aganglionosis (refer to graph in Figure 4B for number of mice analyzed for each mutant 
mouse and associated ENS abnormality). Scale bars: 600 μm (IC junction); 400 μm (distal colon).
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types of these mutant mice indicate that in the context of RET51, the 
Src adaptor site, Grb2-binding site, and the C-term tail are largely 
dispensable for normal ENS (Figure 4B and Table 2) as well as renal 
development (29). Furthermore, these results demonstrate that the 
ENS and genitourinary (GU) systems have different thresholds to 
the loss of RET-Plcγ (results in CAKUT) and RET51-Shc (results in 
HSCR) mediated signaling for normal development.
Docking site mutations in RET9 cause severe ENS defects. The RET9 
isoform differs from RET51 in that it lacks the C-terminal tail that 
contains the Grb2 docking site (Y1096), important for activation of 
the AKT/MAPK pathways. This site provides redundancy to the Src 
and multidocking Shc sites for normal kidney development, as its 
absence in several of the RET9-Tyr mutants leads to increased severi-
ty of kidney abnormalities (29). Therefore, we explored whether this 
site was also important in ENS formation. AChE staining of post-
natal gastrointestinal tracts from mice expressing RET9 mutations 
(Y981F, Y1015F or Y1062F) revealed a spectrum of phenotypes that 
were more severe than those of mice expressing the corresponding 
RET51 mutations. For example, while the ENS of RET51(Y981F) 
mutant mice appeared normal, RET9(Y981F) mice manifested par-
tially penetrant distal intestinal aganglionosis (9/18) in which the 
extent of aganglionosis ranged from the distal third of the colon 
only to the entire colon and terminal ileum (Figure 4). Interestingly, 
the RET9(Y981F) mutant mice previously showed the pattern of 
Figure 4
Severe ENS defects in RET tyrosine docking mutants lacking the Grb2-binding site. (A) Whole-mount AChE staining was used to visualize the 
ENS in P0 intestines in RET9 or the indicated RET9 docking tyrosine mutant mice. Regions of the bowel from the distal colon and duodenum are 
shown. WT RET9 monoisoformic animals have a normal-appearing dense reticular staining pattern in the duodenum and the distal colon, while 
RET9(Y981F) (Src mutants) have colon aganglionosis but normal duodenum staining. RET9(Y1015F) (Plcγ) mice have neuronal ganglia and 
plexus in the colon but at reduced density (hypoganglionosis); duodenum innervation is normal. RET9(Y1062F) mice manifest complete intestinal 
aganglionosis, as no neurons are present in colon or in duodenum. A compound isoformic Y1062F mutant (RET9/51[Y1062F]) has intermediate 
aganglionosis compared with RET51(Y1062F) (Figure 3) and RET9(Y1062F) mice, indicating isoform dosage influences intestinal innervation. 
(B) The bar graph summarizes the innervation phenotypes of all the RET9 and RET51 WT and adaptor mutants examined. Numbers in the bars 
represent the number of mice with that phenotype. Scale bars: 600 μm (duodenum); 400 μm (distal colon).
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incomplete penetrance and variable expressivity in CAKUT (29) 
(Table 2). Thus, abrogated Src adaptor site binding in the face of 
reduced Grb2-mediated signals (i.e., RET9 context) increases the 
propensity to develop both HSCR and CAKUT phenotypes.
In contrast with the abnormalities in the RET9(Y981F) mutants, 
RET9(Y1015F) mutants (lack Plcγ binding) have normal-appearing 
small intestinal innervation and show only a partially penetrant 
distal colon hypoganglionosis (15/17) (Figure 4, A and B). While of 
moderate severity, these colon ENS abnormalities are significantly 
worse than those observed in RET51(Y1015F) mice. We noted that 
the differences in penetrance and severity of ENS deficits between 
RET9-Plcγ and RET51-Plcγ mutants (Figure 4) were not observed in 
the genitourinary system in which both mutants manifested severe 
genitourinary defects (29) (Table 2). We also examined the ENS 
of RET9(Y1062F) mice (lack binding to Shc and other adaptors). 
We found that these mice have complete intestinal agangliono-
sis with 100% penetrance, a phenotype that is similar to Ret-null 
and mouse-human-chimeric-Ret9(Y1062F) mutant mice (19, 31). 
These deficits were more severe than in RET51(Y1062F) mutant 
mice analyzed above in which aganglionosis is limited to the colon 
and further support the idea that Grb2 signaling via the RET51-
specific Y1096 docking site is important for proper development 
of the ENS. Finally, compound isoformic RET(Y1062F) mutant 
mice (RetRET9(Y1062F)/RET51(Y1062F)), which harbor single mutant 
RET9(Y1062F) and RET51(Y1062F) alleles, had an intermediate 
phenotype, with aganglionosis affecting colon and terminal ileum 
that is reminiscent of long-segment HSCR (32) (Figure 4A). We 
did not observe any overt differences between males and females 
for aganglionosis or hypoganglionosis phenotypes in the mutant 
mice analyzed above. Taken together, these results suggest that 
activation of AKT and MAPK signaling through Y1062 that serves 
as a docking site for Shc and other adaptor proteins is necessary 
for complete colonization of the colon.
To further determine the importance of Grb2-mediated signal-
ing in ENS development, we isolated and cultured ENS precur-
sors from E14.5 WT rat bowel using P75 immunoselection (see 
Methods). We infected these with lentiviruses expressing siRNAs 
directed against either Grb2, Shc, or Plcγ and performed analysis 
using TuJ1 and Tau1 immunocytochemistry (33) (see Methods). 
Grb2 knockdown resulted in a marked reduction in enteric neu-
ron number compared with control or Shc siRNA–expressing cells, 
further confirming the essential role of Grb2 in ENS development; 
both Tau1 and TuJ1 immunocytochemistry revealed similar reduc-
tions in neuronal number (Figure 5 and data not shown). The fact 
that Shc knockdown did not have a major effect on enteric neuron 
number suggests redundancy/compensation through other adap-
tors and is consistent with milder ENS phenotype observed in 
RET51(Y1062F) mutant mice, which harbor the additional Grb2-
binding site. Interestingly, Plcγ knockdown also caused a dramatic 
reduction in neuronal numbers despite the minor ENS deficits 
in RET(Y1015F) mice, suggesting that Plcγ activation via signals 
other than RET may be important in ENS development.
Sympathetic nervous system development is relatively resistant to muta-
tion of individual RET docking sites. Artemin-stimulated RET signal-
ing is important for sympathetic neuron precursor migration and 
subsequent axonal projection. To decipher RET-dependent path-
ways that govern sympathetic ganglia formation, we used whole-
mount TH immunohistochemistry to visualize the sympathetic 
nervous system in these RET-mutant mice. We found that indi-
vidual docking sites for Plcγ, Src, Shc, and Grb2 in RET51 iso-
form are all dispensable for sympathetic nervous system develop-
ment (Figure 6, Table 2, and data not shown). When we examined 
mice expressing RET9 with these mutations, we again found few 
deficits in the sympathetic nervous system. These included mod-
erate, unilateral abnormalities in SCG migration, sympathetic 
chain development, and neuronal projection defects in a subset 
of RET9(Y1062F) mutant mice (5/8) (Figure 6). These results are 
in stark contrast to the deficits observed in the ENS and in kidney 
development in these mice (Table 2), suggesting that sympathetic 
nervous system development has a different threshold to aberrant 
Ret-Tyr signaling than other systems or depends on a high degree 
of Ret-mediated signaling redundancy.
Figure 5
Grb2 and Plcγ are essential for maintaining normal enteric neuron 
number. Roles of Grb2, Plcγ, and Shc adaptor proteins in regulating 
enteric neuron number were examined in vitro. ENS precursors were 
harvested from E14.5 rat intestines using p75NTR immunoselection and 
propagated in culture for 7 days. Indicated siRNAs or control (scram-
bled siRNA) were delivered by lentivirus infection 1 day after plating 
the cells. Tau1 immunofluorescence was used to detect neurons and 
their neurites (arrows). Shc siRNA did not affect cell number compared 
with control. Plcγ and Grb2 siRNA caused a severe reduction in neu-
ron numbers. The y axis represents neurons remaining relative to the 
beginning of the culture. The graph at the bottom shows quantification 
results from 3 independent experiments (mean ± SD, *P < 0.05 versus 
control). Scale bar: 25 μm.
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Severe parasympathetic nervous system defects in RET9 docking tyro-
sine mutant mice. In all the RET-dependent organs examined (ENS, 
sympathetic nervous system, kidneys), RET9 docking site mutants 
(lack Grb2 binding at Y1096) manifest more severe defects than 
mice expressing their RET51 counterparts. To extend this analysis 
to the parasympathetic nervous system, we examined SPG devel-
opment in these mutant mice. The SPG failed to develop in a large 
number of RET9-Tyr mutants, and these were generally more severe 
than mice expressing WT RET9 (Figure 2C and Figure 7). For 
example, RET9(Y981F) (lack Src binding) and RET9(Y1015F) (no 
Plcγ binding) mutants showed partially penetrant unilateral and 
bilateral SPG agenesis, with accompanying reduced innervation to 
the harderian gland in the postnatal period (Figure 7, A–C and E). 
Importantly, RET9(Y1062F) mutants (no Shc or Grb2 binding) 
have completely penetrant bilateral SPG agenesis, as observed in 
Ret-null mice (Figure 7A). We counted the number of Nissl-stained 
neurons in these mutant mice using serial sections of the entire 
SPG and found that when the SPG is present (i.e., no agenesis), the 
ganglia contained a normal number of neurons (Figure 7D). Nota-
bly, histological analysis of P0 head sections using Nissl staining 
revealed normal localization of SPGs and normal neuronal num-
bers in all mutants in the RET51 context (Figure 7 and data not 
shown). More severe SPG defects in RET9 mutants again indicate 
that Grb2 signaling from RET51 C terminus is important for nor-
mal development of the parasympathetic nervous system.
Discussion
Inactivating RET mutations are the most commonly identified cause 
of human HSCR and have recently been implicated in renal agenesis 
(3, 7). Activating RET mutations cause MEN2A and MEN2B, famil-
ial cancer predisposition syndromes affecting the adrenal medulla, 
parathyroid, and thyroid (34). Many of these mutations are in the 
cytoplasmic domain of RET. The activation of major signaling pro-
teins such as PLCγ, SRC, PI3K, and MAPK by GFL signaling depends 
on key RET docking tyrosines for intracellular adaptors. One poorly 
understood aspect of these disease associations is the molecular 
mechanisms that underlie organ- or tissue-specific effects of RET 
mutations in human disease and the role of these RET-activated 
pathways in organogenesis. Through the analyses of mutant RET 
allelic series, new insights into the role of RET isoforms and signal-
ing pathways in the ENS and ANS development as well as congeni-
tal diseases caused by RET mutations have been made. In particular, 
through our comparative analyses, we found remarkable specific-
ity in the signaling systems required for each region and demon-
Figure 6
Sympathetic nervous system defects in RET 
mutants lacking Shc and Grb2 binding sites. 
Whole-mount TH immunohistochemistry was 
performed on P0 pups to assess sympathetic ner-
vous system development in RET9 and RET51 
signaling mutants. (A–C) Normal sympathetic 
nervous system develops in (A) RET9(Y981F) 
(Src mutant) and (B) RET9(Y1015F) (Plcγ 
mutant) mice, as demonstrated by normal SCG 
location and normal innervation to submandibular 
gland (SM, black arrowheads) and the eye (blue 
arrowhead). (C) Ret-null mice show abnormal 
caudal location of the SCG, next to the stellate 
ganglion (STG) instead of the expected normal 
location (dashed oval); innervations to the SM or 
the eye are absent. (D–H) RET9(Y1062F) adap-
tor mutants (lack Shc- and Grb2-binding sites) 
show a spectrum of sympathetic nervous sys-
tem defects albeit milder than Ret-null animals. 
These include normal SCG location and projec-
tions to eye (blue arrowhead) and submandibular 
gland (black arrowhead in D), failure of SCG to 
migrate normally (E and F; dashed circle depicts 
expected location), mislocalization of the SCG 
near the stellate ganglion (STG) in G, and fusion 
of rostral sympathetic chain ganglia (black arrow-
head) with the STG, resulting in a gap in the 
sympathetic chain (double arrowhead) in H. (I) 
Sympathetic chain (sc) ganglia in RET9(Y1062F) 
mice are small (black arrows), or absent (dashed 
oval) and have diminished to absent axonal out-
growths compared with WT mice (blue arrows) 
in J. (K–M) Docking site mutations in the context 
of RET51 do not disrupt sympathetic nervous 
system development. Representative pictures 
are shown for the indicated adaptor mutants in 
RET51 context, highlighting normal sympathetic 
ganglia development. Scale bars: 600 μm (A–H 
and K–M); 400 μm (I, J).
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Figure 7
Severe parasympathetic nervous system defects in RET9 docking tyrosine mutant mice. Cranial parasympathetic SPG and their innervation of 
the harderian gland using Nissl staining (P0 pups) and TuJ1 immunohistochemistry (1- to 2-month-old mice), respectively. Refer to Figure 2, 
E–H, for anatomical landmarks for SPG and key for annotations. (A and B) RET9(Y1062F) mice exhibit (n = 14) bilateral SPG agenesis, a 
phenotype similar to that of Ret-null mice (dashed oval, expected normal SPG site); RET51(Y1062F) SPG were normally located (arrows in 
A and B). RET9(Y981F) and RET9(Y1015F) mice showed incomplete penetrance of SPG agenesis, including normal SPG location bilater-
ally (arrows in A), unilateral, or bilateral SPG agenesis (SPG agenesis indicated by dashed ovals in B and summarized in E). (C) Differences 
in innervations (TuJ1 staining, red fibers surrounding each acinus) of the 2 harderian glands from the same mutant mouse. Note that gland 
1 of each mutant had TuJ1-positive fibers surrounding all acini, but gland 2 innervation was markedly decreased or absent, consistent with 
SPG unilateral agenesis (closer view shown in the inset). (D) Summary of SPG neuronal numbers in RET mutants, in which SPG are formed. 
Quantification of neuron numbers in SPG show no significant differences in mutant and WT mice except RET9(Y1062F) mice, which had SPG 
agenesis. The graph depicts number of neurons in each completely sectioned SPG (mean ± SEM; numbers at the bottom denote SPG used 
per genotype). (E) Spectrum of SPG abnormalities observed in RET-mutant mice. Results of SPG location from both RET51 and RET9 mutant 
mice are summarized in the bar graph. Numbers in each colored bar represent the number of SPG with the corresponding defect. Scale bars: 
200 μm (A); 50 μm (B); 100 μm (C); 50 μm (inset).
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strated redundancy in RET-dependent signaling for organogenesis, 
with some mutations affecting the ENS but not renal development, 
whereas others (Plcγ signaling) have more severe effects on kidney 
formation than on the ENS.
One important aspect of our study is the finding that both the 
human RET isoforms, RET9 and RET51, support normal ENS 
and sympathetic nervous system development in mice. Previous 
in vitro studies have presented contrasting views regarding the 
relative importance of these isoforms and each has been touted 
as more crucial (35, 36). An additional study regarding the in vivo 
roles of Ret isoforms concluded that Ret51 could not support 
normal kidney or ENS development, whereas the formation of 
these systems was normal in Ret9-expressing mice (28). In con-
trast, our studies point to redundant roles of the RET isoforms 
in that we observed the development of morphologically normal 
kidneys, ENS, and sympathetic nervous system, with only the 
parasympathetic system demonstrating isoform-specific require-
ments. The reasons for these differing results are unclear and have 
been discussed before (29). These include different properties of 
the chimeric mouse-human Ret51 or Ret9 proteins used in the 
de Graaff study (28) that contain mouse genomic region encom-
passing the extracellular domain versus the cDNAs of the human 
isoforms used in our study (Table 2). There may also be environ-
ment or genetic strain differences that account for our different 
results. Nevertheless, the observations raise the possibility that 
RET isoforms could play alternative roles depending on genetic 
or environmental contexts.
The availability of mice with individual mutations in each 
RET isoform enabled us to systematically determine the role of 
each adaptor site individually in PNS development. In general, 
RET9 mutations caused more severe abnormalities than compa-
rable mutations in the RET51 isoform (Figure 8 and Table 2). For 
example, RET51(Y981F) (Src site) or RET51(Y1015F) (Plcγ site) did 
not prevent colonization of the bowel by ENS precursors, whereas 
these same mutations in the RET9 context resulted in hypogan-
glionosis (Y1015F) or aganglionosis (Y981F) of the distal bowel 
in a large number of animals. Further, mutations in Y1062 also 
caused more severe abnormalities in the RET9 context (complete 
Figure 8
Summary model depicting the main tissues affected by key docking tyrosines activated by GFL-RET signaling. One of the 4 GFLs binds 1 of 
the 4 GFRα coreceptors and forms a multimeric complex with RET leading to receptor activation. The phosphorylated docking sites on each of 
the major isoforms, RET9 and RET51, interact with the indicated adaptors and the signaling cascades. RET9 lacks the extra GRB2-binding site 
(Y1096), and defects in general are more severe and affect more systems when the docking sites are mutated in RET9 context. Asterisks on the 
MAPK/PI3K pathways denote partial reduction due to redundant activation through intact Y1062 or Y1096.
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intestinal aganglionosis) than in RET51 animals (only distal colon 
aganglionosis). Each of these observations suggests an important 
role for Grb2 signaling in ENS development, a hypothesis sup-
ported by our Grb2 knockdown experiments with ENS precursor 
cells and by previous studies in vitro (35, 37, 38). Similar increases 
in the severity of observed defects were found in the parasympa-
thetic and sympathetic ganglia, consistent with an important 
role for Grb2 in GFL-mediated nervous system development. 
Overall, this increased severity may be due to synergistic effects 
on PI3K/AKT and MAPK activity in these RET-dependent tissues 
due to the lack of this additional Grb2-binding site in RET9 mice. 
Biochemical characterization of PI3K/AKT and MAPK activity in 
neurons from these mutant animals showed modest reductions in 
RET9(Y981F) and RET9(Y1015F) mutants and complete abroga-
tion of PI3K/AKT and MAPK activity in RET9(Y1062F) mutants 
(29, 39). These results are consistent with redundancy mediated 
by Grb2 interactions at Y1062 (via Shc) or direct binding at Y1096 
and highlight the differences in RET51 versus RET9 signaling 
properties in vivo (35, 37, 38).
Our studies also identify the molecular signaling pathways that 
lead to the panoply of defects observed in Ret-null mice, includ-
ing renal agenesis and complete intestinal aganglionosis as well as 
parasympathetic and sympathetic nervous system defects. However, 
they also reveal why abnormalities present in the majority of HSCR 
patients, such as colon aganglionosis, can occur without involve-
ment of other organs. For example, the phenotype of RET51(Y1062F) 
mice is very similar to that reported for HSCR caused by a RET 
mutation in the SHC docking site (RET51-M1064T) (40). While the 
cellular processes defective in mice expressing RET(Y1062F) remain 
to be definitively identified in vivo, the phenotypes are most likely 
due to reduced precursor proliferation and migration.
HSCR and CAKUT are complex diseases that can occur singly 
or together (7, 40). The abnormalities in these disorders are often 
complicated by incomplete penetrance and variable expressivity, 
thus making it difficult to delineate the underlying pathogenetic 
mechanisms. RET mutations account for the majority of familial 
and sporadic HSCR and are also found in many cases of renal apla-
sia (4, 41). Our comparative analyses of the PNS and genitourinary 
system development (29) in these RET isoform/docking tyrosine 
mice mutants (Table 2) exhibit remarkable similarities to manifes-
tations of HSCR and CAKUT in humans and provide mechanistic 
insights into how RET-mediated signaling defects may lead to vari-
ous manifestations of these diseases. For example, we discovered 
genetic combinations characterized by similarities to HSCR alone 
(RET51[Y1062F]), CAKUT alone (RET51[Y1015F]), or to a combina-
tion of HSCR and CAKUT (RET9[Y981F] and RET9[Y1062F]). Fur-
thermore, these mutants (e.g., RET51[Y1062F] and RET9[Y981F]) 
exhibit ENS innervation deficits of varying degrees, a prominent 
feature of HSCR, which suggests that aberrant signaling through 
these docking sites underlies the variability in HSCR phenotypes. 
Notably, mutations within the RET cytoplasmic domain have been 
identified in patients with HSCR as well as renal agenesis, although 
to our knowledge not in the key docking tyrosines, as they may be 
detrimental to life. These include mutations within the cytoplas-
mic domain (S767R, Y791F, K907E, E921X/K, M980T, M1064T) that 
affect residues important for kinase activity or autophosphoryla-
tion of the key docking tyrosines (Y981, Y1015, Y1062, and Y1096) 
and that can modulate activation of downstream signaling path-
ways (4, 7, 40, 42–46). Since these docking tyrosines are the major 
effectors of GFL-mediated RET activation, these mutant mice pro-
vide in vivo information regarding the signaling pathways whose 
disruption influences the likelihood and severity of disease in 
patients with CAKUT and HSCR. Importantly, these studies also 
suggest that the relative expression of the 2 RET isoforms could 
play a key role in the severity of these diseases, as signaling through 
Grb2 docking site at Y1096 acts in a synergistic manner with the 
other RET signaling pathways.
Several important observations from our study provide insights 
into the basis for organotypic specificity in CAKUT and HSCR and 
the regulation of PNS and GU development. For example, RET-
stimulated Plcγ signaling (through Y1015) appears to have differ-
ent roles in GU versus PNS development. In the GU system, RET-
Plcγ abrogation results in CAKUT encompassing bilateral defects 
including gonadal dysgenesis, ectopic ureters, distal obstruction, 
and renal branching abnormalities secondary to enhanced Ret sig-
naling, likely due to inhibition of RTK repressors such as Spry1 
(29, 47). However, in enteric and parasympathetic ganglia, cells in 
which Spry1 and Ret do not interact (47, 48), reduced Ret signal-
ing results in reduced ganglia formation. It should be noted that 
among the cranial parasympathetic ganglia, we limited our analy-
ses to the SPG in this study due to complete penetrance of the SPG 
phenotype in Ret-null mice and the relative ease of its analysis and 
analysis of its target, the harderian gland, and thus our results are 
only relevant to the SPG. Overall in the PNS, tyrosine mutations 
in the RET docking site appear to reduce the number of neurons 
and axonal projections. This is consistent with studies of HSCR in 
which variable aganglionosis is observed regardless of the location 
of the mutation (41). However, in the GU system, these key docking 
sites appear to have distinct roles: Plcγ in ensuring only a single kid-
ney is formed and PI3K/MAPK in promoting initiation of kidney 
formation. We also observed that mice expressing RET9 mutations 
that exhibit incomplete penetrance but affect more than one organ 
system (i.e., RET9[Y981], RET9[Y1015F]) do not always manifest all 
the defects, indicating that individual organs have differential sus-
ceptibility or thresholds to the same mutation. For example, defects 
in RET(Y981F) animals include CAKUT with a normal ENS, HSCR 
with normal kidneys, or CAKUT and HSCR together, detected even 
in siblings from the same litter. The basis for these organ-type vari-
ations is not entirely clear and is most likely due to tissue-specific 
modifier genes or epigenetic mechanisms.
Mice evaluated in this work have a wide range of defects in the 
ENS, ANS, and kidneys that mimic human diseases. Although 
certain RET-mediated signaling pathways appear more important 
for some tissues than others, most of the RET9 mutations affect 
at least the ENS, kidney, and parasympathetic nervous systems. 
This suggests that more thorough evaluations of these systems in 
children with HSCR or CAKUT might be useful. In fact, a recent 
study demonstrated that CAKUT anomalies occur in about 25% of 
children with HSCR (7). Furthermore, RET mutations have previ-
ously been detected in patients presenting with MEN2A in com-
bination with either HSCR or CAKUT (4–7). In particular, tests 
for parasympathetic nervous system function (e.g., dry eye disease) 
in individuals with HSCR could be helpful. Finally, our discovery 
that mice expressing RET(Y1015F), which is the docking site for 
Plcγ, have CAKUT along with distal hypoganglionosis suggests 
the possibility of subclinical gastrointestinal dysfunction in these 
patients that may not present as HSCR.
Specificity and redundancy of individual isoforms of a number 
of other RTKs (e.g., Met, PDGFR, insulin receptor, FGFR1) have 
an impact on their biological activities (49, 50). We report here 
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a comprehensive analysis of key signaling pathways activated by 
GFL-mediated RET activation that identified distinct as well as 
redundant roles for ENS, ANS, and kidney development.
Methods
Generation of various RET knockin mice. All animal studies were approved by 
the Washington University Animal Studies Committee. Human RET9, 
RET51, and the indicated mutant cDNAs were homologously recombined 
into the first coding exon of the Ret gene to disrupt synthesis of the endog-
enous mouse Ret as previously described (Figure 1 and Table 1) (29). All 
experiments were performed on homozygous mice with a mixed genetic 
background (129/SvJ:C57BL/6) obtained by breeding of corresponding 
hemizygous parents.
Histopathological and morphological analysis of the PNS. Mouse tissues were 
harvested at the indicated ages, fixed in 4% paraformaldehyde, and pro-
cessed as previously described (11). Routine histological assessment was 
done on H&E-stained tissue sections.
Evaluation of the ENS was done using whole-mount AChE staining on 
dissected gastrointestinal tract of newborn (P0) or postnatal mice. The extent 
of aganglionosis was determined as a percentage of large or small bowel that 
was not colonized by enteric neurons as previously described (11, 51, 52).
Catecholaminergic sympathetic neurons were visualized with diamino-
benzidine by means of whole-mount TH immunohistochemistry (rabbit 
polyclonal antibody, 1:200; Chemicon) on paraformaldehyde-fixed P0 
mouse pups as described (10).
The location and number of SPG neurons was determined from thionin-
stained (Nissl), paraffin-embedded coronal head sections (6 μm) of new-
born mice. Since slight variations in embedding/sectioning angle could 
influence simultaneous appearance of this small ganglion from both sides 
in the same section, the region encompassing the entire ganglion was 
sectioned, and neurons with distinct nucleoli were counted at 120-μm 
intervals (at least 3 animals, 6 ganglia, from each genotype) as previously 
described (11). The histological and anatomical annotation and plane of 
sections are depicted in Figure 2, E–H.
The innervation of intraorbital harderian gland was examined on cryo-
sections (10 μm) of fixed tissue with rabbit class III β-tubulin antibody 
(1:500; Covance) and visualized with Cy3-conjugated anti-rabbit second-
ary antibody (1:200; Jackson Immunoresearch Laboratories). Differences 
in innervation were determined by measuring area covered by Cy3-positive 
profiles (pixel2) in 5 independent fields (×20) from each genotype (n = 3) 
using Metamorph Premier software (Molecular Devices).
Enteric neuron studies in vitro. Enteric neural crest precursors were harvested 
from E14.5 Sprague Dawley rat (Charles River Laboratories) intestines 
using p75NTR antibody (53). Briefly, single-cell suspension was obtained 
after collagenase (1 mg/ml) and dispase (1 mg/ml) dissociation, followed 
by p75NTR antibody incubation (1:1000, 1 hour, 4°C; gift from Moses 
Chao, New York University, New York, NY, USA) in B27-supplemented 
(Invitrogen) Neurobasal medium, and goat anti-rabbit coupled paramag-
netic beads (1:50, 1 hour, 4°C; Miltenyi Biotec) for selective isolation. 
Immunoselected crest-derived cells were plated at a density of 1000 cells 
per well on poly-D-lysine/laminin-coated 8-well chamber slides (Biocoat; 
Fisher) in B27-supplemented Neurobasal medium plus GDNF (50 ng/ml) 
(54). We typically obtained 89% purity (P75-positive) using this method, 
and after 24 hours 80% of cells in culture were Ret-positive, consistent with 
previous studies (55, 56).
Lentivirus-mediated siRNA production and infections were as previ-
ously described (33). Briefly, cells were fixed 7 days after plating (6 days 
after siRNA treatment), and immunohistochemistry was performed with 
TuJ1 (1:1000; Covance) or Tau1 monoclonal antibody (1:100; Chemicon) 
to visualize neurons and axons using epifluorescence microscopy. Char-
acterization of all the adaptor and scrambled control siRNAs including 
specificity and extent of knockdown has been previously described (33). 
The extent of knockdown of each of the adaptor RNAs was reconfirmed in 
cultured enteric neurons using quantitative RT-PCR in 2 to 3 independent 
experiments; Shc (95% knockdown), Plcγ (89% knockdown), and Grb2 (90% 
knockdown). Changes in neuron numbers were determined from a mean 
of 3 separate wells from 3 independent experiments. Statistical significance 
was determined using Student’s t test.
Microscopic and quantitative image analysis. Images for brightfield and 
immunofluorescence on tissue sections (Nikon Eclipse 80i) or whole-
mount specimens (Nikon SMZ1500) were captured (CoolSNAP ES camera 
for fluorescence and CoolSNAP CF for color images) and processed with 
Metamorph and Adobe Photoshop CS software using global adjustments 
in levels, contrast, or brightness.
Statistics. Statistical significance was determined with 2-tailed Student’s 
t test unless otherwise specified. For all studies, the sample size was 3 or 
more for each genotype. The values are represented as mean ± SEM or as 
mean ± SD as indicated, and P < 0.05 was considered significant.
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